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Infection with Plasmodium falciparum during pregnancy is one of the major causes of malaria related morbidity and mortality
in newborn and mothers. The complications of pregnancy-associated malaria result mainly from massive adhesion of
Plasmodium falciparum-infected erythrocytes (IE) to chondroitin sulfate A (CSA) present in the placental intervillous blood
spaces. Var2CSA, a member of the P. falciparum erythrocyte membrane protein 1 (PfEMP1) family is the predominant parasite
ligand mediating CSA binding. However, experimental evidence suggests that other host receptors, such as hyaluronic acid
(HA) and the neonatal Fc receptor, may also support placental binding. Here we used parasites in which var2csa was
genetically disrupted to evaluate the contribution of these receptors to placental sequestration and to identify additional
adhesion receptors that may be involved in pregnancy-associated malaria. By comparison to the wild-type parasites, the
FCR3Dvar2csa mutants could not be selected for HA adhesion, indicating that var2csa is not only essential for IE cytoadhesion
to the placental receptor CSA, but also to HA. However, further studies using different pure sources of HA revealed that the
previously observed binding results from CSA contamination in the bovine vitreous humor HA preparation. To identify CSA-
independent placental interactions, FCR3Dvar2csa mutant parasites were selected for adhesion to the human placental
trophoblastic BeWo cell line. BeWo selected parasites revealed a multi-phenotypic adhesion population expressing multiple
var genes. However, these parasites did not cytoadhere specifically to the syncytiotrophoblast lining of placental cryosections
and were not recognized by sera from malaria-exposed women in a parity dependent manner, indicating that the surface
molecules present on the surface of the BeWo selected population are not specifically expressed during the course of
pregnancy-associated malaria. Taken together, these results demonstrate that the placental malaria associated phenotype can
not be restored in FCR3Dvar2csa mutant parasites and highlight the key role of var2CSA in pregnancy malaria pathogenesis
and for vaccine development.
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INTRODUCTION
Plasmodium falciparum causes the most severe form of human
malaria, with over two million deaths per year. At particular risk of
developing severe, life-threatening malaria-associated complica-
tions are children and women during their first pregnancy [1].
Whereas adults in high transmission regions usually develop
protective clinical immunity to malaria, primigravid women are
highly susceptible to a placental form of infection [2]. Complica-
tions of pregnancy-associated malaria (PAM) result mainly from
massive sequestration of Plasmodium falciparum-infected erythrocytes
(IE) in the placental intervillous blood spaces [3]. Placental
sequestration impacts both mother and fetus, contributing to
premature delivery, intrauterine growth retardation, stillbirth,
maternal anaemia, and increased neonatal and maternal mortality
[4]. Whereas sequestration in the peripheral microvasculature is
associated with IE that bind CD36 and variably to other host
receptors, chondroitin sulfate A (CSA) expressed by placental
syncytiotrophoblasts has been described as a common receptor
involved in IE placental sequestration [3]. With successive
pregnancies, women develop protective antibody responses that
block CSA binding and recognize geographically diverse placental
isolates [5,6], suggesting that a vaccine against PAM is feasible. To
design a vaccine to protect pregnant women and their fetuses, it is
therefore crucial to define the range of host receptors and parasite
ligands involved in placental sequestration.
Cytoadhesion is mediated through the P. falciparum erythrocyte
membrane protein-1 (PfEMP1), encoded by members of the var
multi gene family [7–9]. Gene disruption has been used to show
that var2CSA is the primary PfEMP1 protein mediating CSA-
binding and the only CSA-binding protein that displays a placental
antigenic phenotype [10,11]. However, it is still controversial if
CSA is the only placental receptor involved during PAM.
Therefore if additional host receptors are involved, the corre-
sponding parasite ligands need to be characterized in order to
develop efficient vaccines. Experimental evidence suggests that IE
in the placenta interact with neonatal Fc receptors via surface
bound non-immune IgG [12] and cytoadhere to hyaluronic acid
(HA) [13,14]. Therefore, FCR3Dvar2csa mutant parasites are not
only a useful tool to evaluate if additional PfEMP1 besides
var2CSA have a role in placental IE cytoadhesion, but could also
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In this study, we used FCR3Dvar2csa mutant parasites to
investigate if var2csa is essential for HA cytoadhesion and if the
parasite genome encodes for other parasite ligands that mediate
binding to this receptor. In addition, we used the human placental-
derived trophoblastic BeWo cell line [15–17] to identify other
putative unknown receptors present on the surface of syncytio-
trophoblasts that could play a role in placental sequestration.
Using these approaches, we were unable to define new parasite
adhesion ligands beyond var2CSA that were recognized by sera of
malaria-exposed women in a parity dependent manner. Our
results strongly support the concept that the massive accumulation
of IE in the placenta is predominantly mediated through CSA
specific cytoadhesion and that var2CSA is the key virulence factor
involved in the pathogenesis of PAM.
RESULTS
Var2csa is essential for IE cytoadhesion to purified
hyaluronic acid preparations
Var2csa was previously reported to be transcriptionally upregulated
in both CSA [18,19] and HA binding parasites [20]. To evaluate if
other PfEMP1 besides var2CSA could mediate IE cytoadhesion to
HA, we tested the capability of the FCR3Dvar2csa mutant clone
1F1 to gain a HA binding phenotype upon selection on bovine HA
(bHA) immobilized to plastic Petri dishes. Whereas FCR3-CD36
wild type parasites, displaying a CD36 binding phenotype before
selection, gained binding to bHA after only four rounds of
selection, no specific enrichment was observed for the 1F1
FCR3Dvar2csa mutants (Fig. 1A).
The HA-selected IE adhesion phenotype was further examined
on bHA, CSA and CD36 coated to plastic Petri dishes (Fig. 1B).
While wild type FCR3 IE selected on bHA (FCR3-HA) or with the
CSA binding phenotype (FCR3-CSA) bound to bHA and in
higher numbers to CSA, 1F1 FCR3Dvar2csa mutant clone IE
selected on bHA (1F1-HA) maintained their CD36 binding
phenotype and did not acquire any binding to CSA and bHA
(Fig. 1B). In comparison to the FCR3-CSA IE, 3D7-CSA IE
revealed a very low binding to CSA and no binding to bHA. No
cytoadhesion to BSA or CSC was observed for any of the IE (data
not shown). As expected from previous studies [18–20], FCR3-
CSA and FCR3-HA parasites transcribed a full-length var2csa
transcript, while FCR3Dvar2csa 1F1-HA IE transcribed a trun-
cated non-functional var2csa transcript [10] (Fig. 1C). Further-
more, using a probe to the semiconserved var exon II, transcripts of
around 9 kb were identified in ring-stage RNA of FCR3-CD36
and in the mutant clone 1F1-HA (data not shown). Taken
together, these data indicate that var2csa is essential for cytoadhe-
sion of the late stage FCR3-IE to both the placental receptor CSA
and to bHA and that no other var genes in FCR3Dvar2csa mutants
were able to compensate for HA binding in the absence of var2csa.
Evaluation of the HA binding specificity
Although these results seem to implicate var2CSA as being the
parasite ligand for HA binding, several studies have raised doubts
on the specificity of HA cytoadhesion as it has been reported that
bHA preparations used to select IE contain low to moderate levels
of CSA contamination [21–23]. To test the HA binding specificity
of FCR3-HA IE, binding inhibition assays were performed as
described previously [24] using Streptococcus HA (sHA) preparations
known to be free of CSA from three different commercial sources.
Sonication has been shown to increase HA binding inhibition
activity [24], so HA preparations were tested plus or minus
sonication. Whereas bHA with or without sonication treatment
totally abrogated IE cytoadhesion to bHA coated on plastic Petri
dishes, the three commercially available sources of sHA used in
this study completely failed to inhibit binding to bHA, whether
sonicated or not (Fig. 2A). Furthermore, soluble CSA or bHA were
able to completely cross-inhibit FCR3-HA cytoadhesion to bHA
as well as to CSA (Fig. 2B). In addition, chondroitinase ABC
treatment, but not Streptomyces hyaluronlyticus hyaluronidase treat-
ment inhibited IE adhesion to the two receptors, CSA and bHA
(data not shown). Therefore, binding of FCR3 IE to bHA is caused
by CSA contamination in the HA preparation.
Selection of var2csa disrupted IE on the placental
BeWo cell line and phenotypic analysis
Currently, there are no P. falciparum animal models for placental
sequestration or PAM disease. However, recently, it has been shown
that placental isolates adhere strongly to the human placental-
derived trophoblastic BeWo cell line and that this is a quick and easy
alternative to select IE for the CSA-binding phenotype [15–17]. In
order to identify other putative unknown receptors present on the
surface of syncytiotrophoblasts that could play a role in placental
sequestration, we selected the FCR3Dvar2csa mutant clone 1F1 on
the BeWo cellline.Aftersixpanningsonthe BeWo cellline,the 1F1-
BeWo selected parasite population bound to the BeWo cells,
however, in approximately five-fold lower numbers than the FCR3-
CSA wild type parasites (Fig. 3A). In contrast, 1F1 parasites selected
to bind CD36 did not bind BeWo cells (Fig. 3A).
BeWo cells are heterogeneous cells [25] expressing numerous
potential parasite cytoadhesion receptors including CSA, in-
tercellular adhesion molecule-1 (ICAM-1) [15] and also the
neonatal Fc receptor [12,26]. However, these cells do not express
CD36, CD31, E-selectin and vascular cell adhesion molecule-1
(VCAM-1) [15]. To examine the 1F1-BeWo parasites binding
phenotype, cytoadhesion experiments to different host receptors
coated on plastic Petri dishes were performed. Whereas 1F1-CD36
parasites bound only to CD36, 1F1-BeWo IE adhered in low
numbers to two different sources of recombinant human ICAM-1
and to CD36, but did not bind to CSA (Fig. 3B).
To characterize the respective receptors that FCR3-CSA and
1F1-BeWo IE were using to adhere to BeWo cells, binding
inhibition assays were performed. While antibodies to ICAM-1
had no effect on FCR3-CSA IE adhesion, they inhibited 1F1-
BeWo IE cytoadhesion by 40%, indicating that parts of the
population display an ICAM-1 binding phenotype (Fig. 4A). By
comparison, chondroitinase ABC treatment of the BeWo cells
partially inhibited FCR3-CSA IE cytoadhesion, but 1F1-BeWo IE
binding was not altered (Fig. 4B). No cytoadhesion inhibition of
either parasite line was observed after either hyaluronidase
treatment of the cells or antibodies to CD36 (Fig. 4). These
results demonstrate that the 1F1-BeWo IE binding interaction to
the BeWo cells is CSA and HA independent.
Binding of non-immune IgG on the IE surface of CSA binding
parasites expressing var2CSA such as FCR3-CSA was previously
reported to be involved in IE adhesion to the neonatal Fc receptors
expressed by the syncytiotrophoblasts [12,14]. As BeWo cells have
been described to express the neonatal Fc receptor [26], we
assessed the capacity of FCR3-CSA and 1F1-BeWo IE grown in
the presence of human sera to bind to the BeWo cells. Although
under our experimental conditions non-immune immunoglobulins
can be detected on the surface of BeWo cells and FCR3-CSA IE
but not on the surface of the 1F1-BeWo IE (data not shown), pre-
incubation of late stage FCR3-CSA and 1F1-BeWo IE with
200 mg/ml protein A, but not with BSA, resulted for both parasite
No PAM Phenotype in Var2csa KO
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cells (data not shown). The fact that this partial inhibition was
independent of the parasite phenotype and of the presence of
immunoglobulins on the IE surface suggests a non-specific
inhibition and a minor role for PfEMP1 in this interaction. Taken
together, our data shows that selection of FCR3Dvar2csa parasites
for cytoadhesion to the placental derived BeWo cell line, results in
a CSA-independent, multi-phenotypic parasite population.
Several var genes are transcribed in 1F1-BeWo
parasites
Cytoadhesion of late stage IE is mainly mediated by PfEMP1 that
is encoded by members of the var multi gene family [7–9].
Recently, the var gene repertoire was obtained from the FCR3/
CS2/IT4 parasite genotype [27]. To identify the var gene(s)
predominantly transcribed in the 1F1-CD36 and 1F1-BeWo
parasite populations, gene-specific primers were designed to the 56
known var genes (materials and methods) and quantitative real-
time PCR was performed on RNA extracted from ring stage
parasites at 10 h post-invasion (Fig. 5). Prior to var transcriptional
analysis, 1F1-CD36 IE were reselected on recombinant human
CD36 and 1F1-BeWo parasites were analyzed after six rounds of
selection on the BeWo cells. As expected, both 1F1-derived
parasite lines express a partial, non-functional var2csa transcript as
a result of the gene disruption event [10]. This transcript was
detected by primers to the 59 part of the gene, but not to the 39 end
of the gene. The 1F1-CD36 parasite line also expresses one
dominant var gene, var34, and a second gene at lower level (var47).
The var34 and var47 transcripts are also present in the 1F1-BeWo
parasite population, plus four additional var genes (var5, var6, var7,
and var51) (Fig. 5). These results were confirmed by Northern blot
analysis (Fig. S1). The results of this var gene transcriptional
analysis indicate that the 1F1-BeWo population expressed multiple
var genes displaying a multi-adhesive phenotype.
1F1-BeWo selected parasites do not show
characteristics of placental parasites
The BeWo cell line is considered to be a model that can be used to
study interactions between IE and placental syncytiotrophoblasts.
To test if the 1F1-BeWo parasite line has the characteristics of
Figure 1. Var2csa is essential for IE cytoadhesion to hyaluronic acid. A. Adhesion profiles of P. falciparum infected-erythrocytes during selection on
bHA. Trophozoite-stage P. falciparum FCR3-CD36 and FCR3Dvar2csa 1F1 were subjected to four rounds of selection on plastic Petri dishes coated
with bHA. Mean numbers (6SD) of IE adhering per mm
2 for four different fields are shown. B. FCR3-HA IE cytoadhere to CSA and HA coated to plastic.
Erythrocytes infected with P. falciparum FCR3-CSA, 3D7-CSA, FCR3-CD36, FCR3Dvar2csa 1F1 and the parasites selected on HA FCR3-HA and 1F1-HA
were analyzed for cytoadhesion to CSA (white bars), bHA (dark gray bars) or CD36 (light gray bars). Data are the mean number (6SEM) of IE per mm
2
adhering to receptor-coated plastic Petri dishes, as determined in two independent assays in duplicate spots. C. Northern blot analysis of total RNA
isolated from ring (R) and trophozoite stage parasites (T) FCR3-CD36, FCR3-CSA
BeWo DMSO, FCR3-CSA
BeWo Forskolin, FCR3-HA and the HA-selected
FCR3Dvar2csa clone 1F1-HA. The membrane was hybridized with a probe specific for var2csa DBL1-X. The 1F1-HA gene disruption parasite
constitutively expresses a truncated, non-functional var2csa transcript [10], which explains the lower molecular weight product in these lanes.
doi:10.1371/journal.pone.0000910.g001
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normal human placenta cryosections under flow conditions at
0.05 Pa. In this experiment, FCR3-CSA parasites, used as
a control, adhered mainly to the syncytiotrophoblast lining. In
contrast, 1F1-BeWo and 1F1-CD36 IE showed weaker binding
and adhered mostly to the villous tissue and not specifically to the
syncytiotrophoblast lining (Fig. 6A, and data not shown). To
examine whether 1F1-BeWo selected parasites were recognized in
a gender-specific manner they were tested by flow cytometry and
live immunofluorescence assay using sera from Malawian male
and pregnant women. Using these sera, only FCR3-CSA IE were
recognized by sera pools of malaria-exposed women in a parity
dependent manner (Fig. 6B and C). In contrast, FCR3-CD36,
1F1-BeWo and 1F1-CD36 were recognized equally well by sera
pools of malaria-exposed males, primigravid and multigravid
women (Fig. 6B and C). Taken together, the low binding to the
syncytiotrophoblast lining and the parity independent surface
reactivity suggest that erythrocyte surface molecules expressed by
1F1-BeWo selected population are not specifically expressed
during the course of pregnancy-associated malaria.
Figure 2. Binding of the FCR3-HA selected parasites to HA and CSA is inhibited by soluble bovine HA and soluble CSA, but not by Streptococcus
HA. A. Evaluation of the HA binding specificity of the FCR3-CD36 IE selected on HA was determined without (control) or with 200 mg/ml of different
HA preparations sonicated or not in the binding medium. HA from bovine vitreous humor (bHA) and different HA from Streptococcus (sHA) were
tested for their ability to inhibit IE binding to bHA. Data are the mean number (6SEM) of IE per mm
2 adhering to receptor-coated plastic Petri dishes,
as determined in three independent assays in duplicate spots. B. Soluble bHA and CSA cross-inhibit cytoadhesion of FCR3-HA IE to bHA as well as
CSA. FCR3-HA IE were pre-incubated with 200 mg/ml soluble CSA as well as untreated or treated bHA prior to the binding assay. The ability to inhibit
IE cytoadhesion to bHA (left panel) and CSA (right panel) was examined. Data are the mean number (6SEM) of IE per mm
2 adhering to receptor-
coated plastic Petri dishes, as determined in three (A) or two (B) independent assays in duplicate spots.
doi:10.1371/journal.pone.0000910.g002
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PLoS ONE | www.plosone.org 4 September 2007 | Issue 9 | e910Figure 3. Phenotypic analysis of FCR3Dvar2csa 1F1 IE selected on the human placental derived trophoblastic BeWo cell line. A. Cytoadhesion of
IE to BeWo cells was compared for the FCR3Dvar2csa clone 1F1 selected on BeWo cells (1F1-BeWo), the 1F1 control parasites selected on
recombinant human CD36 (1F1-CD36) and the wild-type FCR3-CSA parasites. Data are the mean number (6SEM) of IE per mm
2 adhering to BeWo
cells as determined in at least two independent assays in duplicate. B. Erythrocytes infected with P. falciparum 1F1-CD36 (white bars) and 1F1-BeWo
(gray bars) were analyzed for cytoadhesion to CSA, CD36 (left panel), recombinant human ICAM-1 (rhICAM-1) and ICAM-1 Fc (right panel). Data are
the mean number (6SEM) of IE per mm
2 adhering to receptor-coated plastic Petri dishes as determined in at least two independent assays in
duplicate.
doi:10.1371/journal.pone.0000910.g003
Figure 4. Anti-ICAM-1 antibody inhibits 1F1-BeWo IE binding to BeWo cells. A. and B. Binding specificity of FCR3-CSA (white bars) and 1F1-BeWo IE
(gray bars) to BeWo cells was determined using various inhibitors. BeWo cells were either pre-incubated with adhesion blocking anti-ICAM-1 or anti-
CD36 antibodies at 5 mg/ml (A) or pre-treated with Streptomyces hyaluronlyticus hyaluronidase (25 units/ml) or chondroitinase ABC (0.5 units/ml) for
1 h at 37uC( B). Data are the mean percentage (6SEM) of IE binding compared to the appropriate control as determined in three independent
experiments.
doi:10.1371/journal.pone.0000910.g004
No PAM Phenotype in Var2csa KO
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Cytoadhesion of late stage IE in the placenta is a crucial event in
the development of severe malaria complications during pregnan-
cy especially in primigravid women [28]. Although it is generally
accepted that a vaccine that would protect against PAM should
target the var2CSA molecule, a crucial question remains to be
addressed, namely if non-CSA mediated adhesion events could
replace CSA adhesion in the placenta. Using our recently
described var2csa deficient parasite line FCR3Dvar2csa 1F1 [10],
we were able to evaluate the role of non-CSA placental adhesion
receptors.
In this study, we showed that var2csa is linked to the interaction
with certain HA preparations bound to plastic and that this
phenotype is lost in var2csa deficient mutant parasites. However,
we failed to prove the specificity of HA in the binding assays,
leading us to the conclusion that binding of IE to bHA is mediated
by CSA contamination in the HA preparation. These results are in
disagreement with several studies reporting HA specific IE
cytoadhesion [13,14,24,29,30], but supported by other studies
that raised doubts on the specificity of HA mediated IE
cytoadhesion [22,23,31]. More recently, Muthusamy et al.
demonstrated that HA is not present in the intervillous space of
the human placenta [31], indicating that HA is unlikely to be
involved in placental sequestration.
In addition to CSA and HA, the binding of non-immune
immunoglobulins to the IE surface was reported to be an
important ligand for IE adhesion to the placental syncytiotropho-
blasts via neonatal Fc receptors [12]. This study implicated a non-
var2csa-type var gene (TM284S2 var1) in placental binding. To
address whether other parasite ligands can supplant placental
binding in the absence of functional var2CSA, we selected 1F1
FCR3Dvar2csa mutant parasites on BeWo cells. We obtained
a parasite line that displayed a mixed, but CSA-independent
binding phenotype. 1F1-Bewo cells adhered much weaker than
Figure 5. Transcriptional analysis of var genes in 1F1-CD36 and 1F1-BeWo parasite lines. Prior to selection, the FCR3Dvar2csa clonal line 1F1
bound CD36. The 1F1 parasite line was reselected on either human recombinant CD36 (top panel) or six times on BeWo cell lines (bottom panel)
before var transcriptional analysis. Both 1F1-derived parasite lines express a partial, non-functional var2csa transcript as a result of the gene
integration event [10]. The partial var2csa transcript is detected by primers to the 59 part of the gene, but not to the 39 end of the gene. The 1F1-CD36
parasite line expresses one dominant var gene, var34, and a second gene at lower level (var47). The var34 and var47 transcripts are also present in the
1F1-BeWo parasite line, plus four additional var genes (var5, var6, var7, and var51).
doi:10.1371/journal.pone.0000910.g005
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PLoS ONE | www.plosone.org 6 September 2007 | Issue 9 | e910FCR3-CSA IE to BeWo cells. This observation supports previous
results indicating that var2CSA is the primary ligand for CSA in
the FCR3 genotype. The CSA-independent IE adhesion with
BeWo cells was investigated for its possible interaction with the
neonatal Fc receptor. IE adhesion to the BeWo cells was partially
inhibited with protein A. This inhibition was, however, in-
dependent of the parasite phenotype and of the presence of
immunoglobulins on the IE surface, suggesting a non-specific
inhibition and a minor role for PfEMP1 in this interaction. In
addition, several studies have concluded that neonatal Fc receptors
are not expressed on the syncytiotrophoblasts surface and may
therefore not be accessible to IE cytoadhesion [32–34]. Taken
together, our data show that the neonatal Fc receptor is not
a major placental cytoadhesion receptor for FCR3 parasites under
the experimental conditions.
To assess the potential role of non-var2CSA PfEMP1 variants in
PAM pathogenesis, we characterized the binding and antigenic
phenotype of BeWo selected parasites. By comparison to FCR3-
CSA IE expressing var2csa, 1F1-BeWo IE do not sequester
specifically to the syncytiotrophoblast lining of normal human
placental cryosections nor are they recognized in a gender-specific
manner by endemic sera suggesting they are not expressed during
the course of pregnancy-associated malaria.
Similar to our work, Duffy et al. [11] have generated var2csa-
disruption mutants in a parasite line, termed CS2, which is
isogenic to the FCR3 parasite used here. While CS2Dvar2csa were
able to weakly recover a CSA-binding phenotype, these minor
variants were not recognized by pregnant women sera in a parity
dependent manner and therefore are unlikely to have an
important role in pregnancy associated malaria. Recently, the
Figure 6. No specific cytoadhesion of 1F1-BeWo IE to placental syncytiotrophoblasts and no parity dependent sera recognition. A. Binding of
late stage IE to syncytiotrophoblasts of normal human placenta cryosections under flow conditions at a shear stress of 0.05 Pa. Data shown are the
percentage (6SD) of IE bound to the syncytiotrophoblasts versus IE bound in total as determined in three independent experiments on cryosections
of two different placentas in duplicate. B and C. Recognition of IE with different binding phenotypes by sera pools of Malawian malaria exposed
males (white bars), primigravid (light gray bars) and multigravid women (dark gray bars). Analysis was performed using flow cytometry (B) and
fluorescence microscopy (C). Flow cytometry data shown are the mean values of the geometric mean fluorescence intensities (FI) (6SD) for the
samples.
doi:10.1371/journal.pone.0000910.g006
No PAM Phenotype in Var2csa KO
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parasite genotype [27]. Interestingly, the varP gene tag described
to be upregulated in these CS2 var2csa deficient mutants is
identical to the var6 gene upregulated in our 1F1-BeWo parasite
line. Therefore it is possible that the var6 protein possesses a very
low affinity CSA binding domain. However, none of the var genes
upregulated in 1F1-BeWo parasites has significant relationship to
the TM284S2 var1 gene [12], which, unlike var2csa, is not
conserved across P. falciparum isolates.
While the new var genes upregulated on BeWo-selected IE are
unlikely to have a role in PAM pathogenesis, they do provide new
information about var-associated binding phenotypes. Whereas
1F1-CD36 parasites bound only to CD36, 1F1-BeWo IE adhered
in low numbers to human ICAM-1 and to CD36. As the 1F1-
CD36 parasites do not bind to ICAM-1 we can exclude that var34
and var47 are involved in the observed 1F1-BeWo ICAM-1
binding phenotype. As BeWo cells do not express CD36, the
CD36 binding phenotype of 1F1-BeWo likely arose due to
a PfEMP1 variant that happened to encode CD36 binding activity
function in addition to the host receptor adhesion trait that led to
its selection on BeWo cells. This is not surprising because CD36
binding is a common adhesion trait in many different PfEMP1
variants [35]. Because var34 is found in FCR3 parasites with
different phenotypes we suggest that high ‘‘on’’ rates for the var34
var gene in FCR3 parasites may explain the frequently observed
subpopulation expressing var34.
With regard to the development of a vaccine aiming to protect
pregnant women and their fetuses from severe disease, our results
are encouraging. Using FCR3 parasites and a defined placental
binding model, we were unable to confirm a role for HA as well as
for non-immune immunoglobulins in IE placental sequestration
nor to select for additional parasites with a placental antigenic
phenotype, besides var2CSA. Although we cannot exclude that by
using another laboratory strain or another selection system we
would have observed the same data, our experimental findings
strongly point to var2CSA as the main parasite ligand mediating
high affinity and high density cytoadhesion to the placenta.
Compared to typical PfEMP1 proteins, var2CSA is exceptionally
conserved between parasite isolates from different regions of the
world [36,37]. This could help explain how multigravid women in
malaria endemic areas develop antibodies that recognize erythro-
cytes infected with placental and CSA binding parasites in a strain
transcendent manner. In conclusion, the analysis of a mutant
parasite (var2csa KO) has been a valuable tool to reevaluate
previously described interactions of IE with the placenta. Our
results indicate that vaccine development should focus on the
var2CSA molecule.
MATERIALS AND METHODS
Parasite and cell culture
The P. falciparum FCR3 and 3D7 strains were cultivated according
to standard conditions [38] in O+ human erythrocytes in RPMI
1640 containing L-Glutamine (Invitrogen) supplemented with 5%
human serum (PAA Laboratories GmbH), 0.25% Albumax I
(Invitrogen), 16hypoxanthine (c.c.pro) and 20 mg/ml gentamicin
(Sigma). FCR3Dvar2csa clone 1F1 [10] was grown in the presence
of 2.5 nM WR99210 (Jacobus Pharmaceutical Company). For
selection on BeWo cells and for flow cytometry, parasites were
grown in RPMI 1640 containing L-Glutamine supplemented with
0.5% Albumax I, 16 hypoxanthine and 20 mg/ml gentamicin.
Cultures were synchronized as described previously [39]. To
maintain knob-positive parasites, cultures were routinely selected
by gelatin flotation using Plasmion (Fresenius Kabi) [40]. The
human choriocarcinoma placenta BeWo cell line was cultured as
described [15]. Parasites and cells were tested Mycoplasma negative
by PCR.
Binding phenotype selection
To select the FCR3 strain and the FCR3Dvar2csa clone 1F1 for
specific binding phenotypes, trophozoite-stage parasitized erythro-
cytes (IE) were purified using Plasmion and selected either on
BeWo cells or on plastic Petri dishes coated with bHA or
recombinant CD36.
To obtain a CSA-binding phenotype, FCR3-CSA and 3D7-
CSA IE used in this study were selected on the trophoblastic
BeWo cell line as described recently [15].
Plastic Petri dishes (Falcon #1005) were coated overnight at
4uC with PBS containing 100 mg/ml HA sodium salt from bovine
vitreous humor (Sigma) or 10 mg/ml recombinant human CD36-
Fc (R&D Systems), washed three times with PBS and blocked with
1% BSA for 1 h at RT, before trophozoite-IE were allowed to
adhere. All assays were carried out using RPMI 1640/25 mM
Hepes, pH 7.2 (panning buffer). BeWo cells were washed three
times with panning buffer, before IE were allowed to adhere. For
gelatin enrichment, 1 ml RBC pellet was mixed with 1.4 ml of
parasite culture medium and 2.4 ml of Plasmion and incubated for
30 min in a 37uC water bath. The enriched IE were washed twice
with panning buffer and were resuspended in 10 ml of panning
buffer at a concentration of approximately 5610
7 IE/ml. After
incubation at 37uC in a 5% CO2 incubator for 1 h with gentle
agitation every 15 min, non-adherent IE were washed away with
panning buffer. Bound IE were detached with the pipette stream
and returned to culture. Parasites were grown to a parasitemia of
4–10% before repeating this process three times for selection on
bHA, five times for selection on BeWo cells.
Cytoadhesion assays on immobilized receptors
Cytoadhesion assays on receptors immobilized on plastic petri
dishes were carried out as described [41,42]. Briefly, plastic Petri
dishes were coated overnight at 4uC with PBS containing 1 mg/ml
CSA sodium salt from bovine trachea (Sigma), 1 mg/ml
chondroitin sulfate C sodium salt from shark cartilage (CSC)
(Sigma), 100 mg/ml HA sodium salt from bovine vitreous humor
(Sigma), 10 mg/ml recombinant human ICAM-1/Fc Chimera
(R&D Systems), 10 mg/ml recombinant human ICAM-1 (R&D
Systems), 1% BSA or MAb 179 (25 mg/ml) [41]. MAb 179 coated
spots were incubated with recombinant CD36 protein containing
this epitope tag for 1 h at RT. All spots were blocked with 1%
BSA for 1 h at RT before trophozoite-IE (5610
7 IE/ml) were
allowed to adhere. The average number of adherent IE (6SEM)
for four different fields in duplicate spots was determined in two to
three independent experiments after fixing with 2% glutaralde-
hyde in PBS for 2 h at RT and staining the plates with Giemsa.
Pictures were taken with a Nikon camera. Lucia software was used
to determine the number of bound IE.
Inhibition assays on immobilized receptors
HA of the different sources was dissolved overnight at 4uCo n
a rotating wheel at a concentration of 5 mg/ml in water. The
solutions were treated by intermittent sonication, in an ice water
bath, for 5 min using a Bioruptor (Diagenode) set at maximum
output with 30 sec/30 sec intervals. Control HA samples were
incubated in an ice water bath for an equivalent time. HA from
bovine vitreous humor (Sigma), Streptococcus sp. (Calbiochem),
Streptococcus equi (Fluka) and Streptococcus zooepidemicus (Sigma) was
tested. CSA was dissolved in PBS at a concentration of 5 mg/ml.
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7 IE/ml were pre-incubated with 200 mg/ml of the different
soluble HA preparations for 30 min at RT and adding the soluble
inhibitors to the binding assay. 200 mg/ml CSA was used as
a positive control for inhibition of cytoadhesion.
Inhibition assays on BeWo cells
Specificity of IE binding to the BeWo cells was determined using
various inhibitors. Cytoadhesion assays were carried out as
described recently [15]. Binding specificity was determined either
by pre-treating the BeWo cells with 0.5 units/ml of chondroitinase
ABC (Fluka) or 25 units/ml Streptomyces hyaluronlyticus hyaluroni-
dase (Calbiochem) or by pre-incubating the cells with 5 mg/ml
anti-CD36 monoclonal antibody FA6/152 (Beckman Coulter) or
5 mg/ml anti-ICAM-1 monoclonal antibody 84H10 (Beckman
Coulter) for 1 h at 37uC. Whereas enzyme treated cells were
washed prior to IE adhesion, antibodies remained present during
adhesion assays. IE were pre-incubated with the soluble inhibitor
protein A from Staphylococcus aureus (200 mg/ml) or with 200 mg/ml
BSA for 20 min at RT. Cytoadhesion assays were carried out in
panning buffer pH 7.2. Pictures of cells were taken with a Nikon
camera after fixing cells with 2% glutaraldehyde in PBS.
Flow adhesion assays
Adhesion assays to normal human placenta cryosections under
flow conditions at a shear stress of 0.05 Pa were performed as
described [43].
Flow cytometry
Cultures with 3–5% parasitemia synchronous at the mid/late
trophozoite stage were washed three times in PBS/0.2% BSA and
resuspended in PBS/0.2% BSA to 1610
7 cells/ml. Samples were
stained for 30 min at RT with sera pools of malaria-exposed male,
primigravidae and multigravidae from Malawi (1:20 dilution) [44].
Sera were collected from pregnant women near delivery. All
women gave written consent for HIV counselling and testing, and
for the use of their sera to investigate immunity to malaria. Only
HIV uninfected women’s sera were used in the present study.
Samples from males were collected from fathers of children
admitted to the same hospital with malaria, who gave witnessed
verbal consent. The use of these sera was approved by the College
of Medicine Research Ethics Committee, University of Malawi.
After washing three times with PBS/0.2% BSA, IE were incubated
with PBS/0.2% BSA containing anti-human IgG Alexa488 (1:100)
(Invitrogen) and 10 mg/ml ethidium bromide for 30 min at RT.
IE were washed with PBS/0.2% BSA and fixed in 4%
paraformaldehyde/PBS over night at 4uC. Analysis was carried
out on a FACScan using CellQuest software (BD Biosciences).
Data given are the mean values of the geometric mean
fluorescence intensities (FI) (6SD) as determined in two in-
dependent experiments.
RNA extraction and real-time RT-PCR for assaying
expression of the var gene family
RNA was extracted from synchronized ring stage parasites ,10 h
post-invasion using TRIZOL LS Reagent (Invitrogen). RNA was
treated with recombinant Deoxyribonuclease I (Ambion) to
degrade contaminating DNA. cDNA synthesis was performed
using Multi-Scribe reverse transcriptase (Applied Biosystems) with
random hexamer primers (Applied Biosystems). cDNA was
synthesized from 4 mg total RNA and one half of this material
was used for each real-time comparison. Real-time reactions were
performed at optimized final primer concentration of 0.05 mM–
0.5 mM using Biorad ITAQ SYBR green Supermix in 40 ml
reactions on an ABI Prism 7000. Each var gene comparison was
performed in triplicate using cDNA from at least two different
RNA preparations. Real-time primers and optimized primer
concentrations are listed in Table S1. PCR cycling conditions were
50uC for 1 min, 95uC for 3 min followed by 40 cycles of 95uC for
15 s, 52uC for 15 s and 60uC for 1 min. To validate the IT4 var
primer pairs, they were first tested by real-time PCR on genomic
DNA and the median cycle threshold (CT) value was calculated.
Using published criterion [18], all primer pairs were optimized
until individual CT values were within 1.5 cycles of the median CT
value. The specificity of each primer pair was confirmed by direct
sequencing of PCR products amplified from genomic DNA.
For var transcriptional analyses, var gene normalization was
done by comparison to adenylosuccinate lyase (PFB0295w).
Adenylosuccinate lyase was chosen as a control because it displays
relatively uniform transcription throughout the bloodstage parasite
development [45]. Two other control genes, glutaminyl-tRNA
synthetase (PF13_0170) and arginyl-tRNA synthetase (PFL0900c)
that have been employed in previous var transcripition analysis
[46] were included in some reactions and gave similar results to
adenylosucciante lyase. The IT4 var primer pairs and control
primers were first shown to have similar amplification efficiencies
by performing amplifications using different concentrations of
genomic DNA template. After optimizing primers efficiencies,
residual primer bias was corrected by calculating the average
difference in CT values between each optimized IT4 var primer
pair and adenylosuccinate lyase using genomic DNA as template,
as described previously [46]. Following var transcriptional analyses,
the D CT for each individual primer pair was determined by
correcting for primer bias using the above calculation, and then
subtracting the individual CT value from the CT value of the
control adenylosuccinate lyase. D CTs were converted to relative
copy numbers with the formula 2
DCT (User bulletin 2, Applied
Biosystems, http:www.appliedbiosystems.com).
Northern blot Analysis
Total RNA was prepared from synchronized parasite cultures
approximately 10 h and 30 h post-invasion, respectively. RNA
preparation, electrophoresis, membrane transfer and hybridization
were carried out as previously described [47]. The membrane was
hybridized at high stringency conditions at 60uC overnight and
washed twice with 0.56SSC, 0.1% SDS at 60uC for 30 min. The
probe for FCR3 var2csa DBL1-X was generated by PCR
amplification from FCR3 genomic DNA using the primers 59-
tccccgcggcattcagattctggaaagtatgatcc-39 and 59-ggactagtttcaagagac-
gaataattagcttcaag-39 and radiolabelling as previously described
[19].
SUPPORTING INFORMATION
Table S1
Found at: doi:10.1371/journal.pone.0000910.s001 (0.09 MB
DOC)
Figure S1 Transcriptional analysis of var genes Northern blot
analysis of total RNA isolated from ring (R) and trophozoite stage
parasites (T) FCR3-CSA, FCR3-CD36, 1F1-CD36 and 1F1-
BeWo. The membrane was hybridized with probes specific for
var2csa DBL1, var6 DBL3c, var7, var34, var47 and semi-conserved
varT11.1 exon II. The Northern blot data confirms the
quantitative real-time PCR data that several different full-length
var genes are transcribed in the multi-phenotypic parasite
population 1F1-BeWo. The probes were generated by PCR
No PAM Phenotype in Var2csa KO
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previously described [19]. For the var probes following primers
were used: var6: gaagacgaaaattatgcgtaagtag and caagcgttagcacaac-
tagtcttaccg, var7: ggacattgttggaaagacagtgc and cattctgcccattcagt-
catcc, var34: caaaccaaaaccagatggaggtc and cgtgtattcgccgttgtccttg,
var47: aaccacaagatagtgctggcggac and cttcaaggtaacggaaataagggg.
Found at: doi:10.1371/journal.pone.0000910.s002 (1.55 MB
DOC)
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